Patents Assigned to ASTRAZENECA LP
  • Prevention And Treatment Of Cardiac Arrhythmias
    Publication number: 20130209586
    Abstract: Compositions of the invention, including compounds that bind to a receptor for a glucagon-like peptide-1, an incretin, a glucagon-like peptide-1 (GLP-1), an exendin, or an agonist, an analog (preferably an agonist analog), a derivative, or a variant of any of aforementioned compounds, are used in the prevention and treatment of arrhythmias associated with cardiac ischemia, cardiac ischemia-perfusion and/or congestive heart failure. The invention relates to both the method and compositions for such treatment.
    Type: Application
    Filed: March 4, 2013
    Publication date: August 15, 2013
    Applicants: ASTRAZENECA LP, AMYLIN PHARMACEUTICALS, LLC
    Inventors: AMYLIN PHARMACEUTICALS, LLC, ASTRAZENECA LP